Lv Longxian, Li Gaolei, Chen Jinhui, Liang Xinle, Li Yudong
State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China.
Department of Biological Engineering, School of Food Science and Biotechnology, Zhejiang Gongshang Univeristy, Hangzhou, China.
Front Microbiol. 2020 Nov 30;11:584717. doi: 10.3389/fmicb.2020.584717. eCollection 2020.
The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Wuhan, China, rapidly grew into a global pandemic. How SARS-CoV-2 evolved remains unclear.
We performed a comprehensive analysis using the available genomes of SARS-CoV-2 and its closely related coronaviruses.
The ratio of nucleotide substitutions to amino acid substitutions of the spike gene (9.07) between SARS-CoV-2 WIV04 and Bat-CoV RaTG13 was markedly higher than that between other coronaviruses (range, 1.29-4.81); the ratio of non-synonymous to synonymous substitution rates (dN/dS) between SARS-CoV-2 WIV04 and Bat-CoV RaTG13 was the lowest among all the performed comparisons, suggesting evolution under stringent selective pressure. Notably, the relative proportion of the T:C transition was markedly higher between SARS-CoV-2 WIV04 and Bat-CoV RaTG13 than between other compared coronaviruses. Codon usage is similar across these coronaviruses and is unlikely to explain the increased number of synonymous mutations. Moreover, some sites of the spike protein might be subjected to positive selection.
Our results showed an increased proportion of synonymous substitutions and the T:C transition between SARS-CoV-2 and RaTG13. Further investigation of the mutation pattern mechanism would contribute to understanding viral pathogenicity and its adaptation to hosts.
严重急性呼吸综合征冠状病毒2(SARS-CoV-2)在中国武汉爆发,并迅速演变成一场全球大流行。SARS-CoV-2如何进化仍不清楚。
我们使用SARS-CoV-2及其密切相关冠状病毒的现有基因组进行了全面分析。
SARS-CoV-2 WIV04与蝙蝠冠状病毒RaTG13之间刺突基因的核苷酸替换与氨基酸替换的比率(9.07)明显高于其他冠状病毒之间的比率(范围为1.29 - 4.81);在所有进行的比较中,SARS-CoV-2 WIV04与蝙蝠冠状病毒RaTG13之间的非同义替换率与同义替换率之比(dN/dS)最低,表明在严格的选择压力下进化。值得注意的是,SARS-CoV-2 WIV04与蝙蝠冠状病毒RaTG13之间T:C转换的相对比例明显高于其他比较的冠状病毒之间。这些冠状病毒的密码子使用情况相似,不太可能解释同义突变数量的增加。此外,刺突蛋白的一些位点可能受到正选择。
我们的结果显示了SARS-CoV-2与RaTG13之间同义替换比例增加以及T:C转换。对突变模式机制的进一步研究将有助于理解病毒致病性及其对宿主的适应性。